Wockhardt
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Wockhardt sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).
Wockhardt: 27 sponsored US clinical trials, none currently recruiting.
Wockhardt sponsors 27 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 26 completed. 2 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Subjects (HS), with 1 trials.
Top-decile sponsor footprint
Wockhardt ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
26 of 27 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
27 total, page 1 of 1
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
NCT06806995
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
NCT04979806
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin
NCT03981887
To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)
NCT03622008
Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.
NCT07247942
Plasma and Intrapulmonary Concentrations Study of WCK 5222
NCT03630094
Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
NCT03554304
Phase II Study of Oral Nafithromycin in CABP
NCT02903836
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment
NCT02942810
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
NCT02770404
A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment
NCT02709382
MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers
NCT02707107
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
NCT02674347
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
NCT02532140
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
NCT02453529
Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects
NCT02253342
Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment
NCT02244827
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers
NCT02217930
Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers
NCT01875939
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771
NCT05640531
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM
NCT01357603
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
NCT01308437
Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects
NCT01358435
Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects
NCT00772265
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
NCT00752180
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.
NCT00719108
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.
NCT00596063
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 24 |
| Phase 2 | 1 |
| Phase 3 | 2 |
How the Wockhardt early-phase archive is shaped
27 indexed studies, none listed as recruiting (0% open); 26 completed (96%).
Phase mix: 2 late (III/IV) vs 25 early (I/II) (early-phase heavy).
Top condition: Healthy Subjects (HS) (1 trial), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Wockhardt: archived-pipeline peers nationwide
Peers matched on 27 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Wockhardt sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 27 archived trials
- Akron Children's Hospital · 27 trials · 7% recruiting
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) · 27 trials · 0% recruiting
- AVEO Pharmaceuticals · 27 trials · 7% recruiting
- Dompé Farmaceutici S.p.A · 27 trials · 15% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Wockhardt page
27 registered trials is a research-attention snapshot, not an endorsement of Wockhardt or any single study.
- None of Wockhardt's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy Subjects (HS) is the condition Wockhardt studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Subjects (HS) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wockhardt pipeline card: 27 registered trials from official public datasets.Report a data error.